C-Suite Perspectives on the Mid-Revenue Cycle: New Insights from 80 Health System Leaders

Ever wonder what CFOs, Chief Revenue Cycle Officers, and other senior RCM executives at health systems ranging from $750M to $15B+ in net patient revenue actually think about the mid-revenue cycle? The risks, potential... and where AI fits into all of it? 

We partnered with The Health Management Academy to find out. Check out the replay from this webinar where our CMO Ruben Amarasingham, MD, uncovers the results alongside Universal Health Services' VP of Revenue Cycle Mark Cannon.